Search filters

List of works by Alessandra Mosca

Bone metastases affect prognosis but not effectiveness of third-line targeted therapies in patients with metastatic renal cell carcinoma

scientific article

CHANGES IN FREE AND FREE-TO-TOTAL PROSTATE SPECIFIC ANTIGEN AFTER ANDROGEN DEPRIVATION OR CHEMOTHERAPY IN PATIENTS WITH ADVANCED PROSTATE CANCER

scientific article published on 01 January 1999

Changes in Bone Mineral Density After Adjuvant Aromatase Inhibitors and Fracture Risk in Breast Cancer Patients

scientific article published on 01 April 2007

Chromogranin A expression in patients with hormone naïve prostate cancer predicts the development of hormone refractory disease.

scientific article

Clinical outcome of patients who reduced sunitinib or pazopanib during first-line treatment for advanced kidney cancer.

scientific article published on 29 May 2017

Clinical outcomes in patients receiving three lines of targeted therapy for metastatic renal cell carcinoma: results from a large patient cohort

scientific article published on 18 March 2013

Comparison between two commercially available chromogranin A assays in detecting neuroendocrine differentiation in prostate cancer and benign prostate hyperplasia

scientific article published on 05 September 2006

Could the efficacy of docetaxel in prostate cancer patients be potentiated by concomitant high-dose calcitriol administration?

scientific article published in April 2008

Docetaxel plus androgen deprivation withdrawal may restore sensitivity to luteinizing hormone-releasing hormone analog therapy in castration-resistant prostate cancer patients.

scientific article published on 21 December 2015

Effects of the somatostatin analog lanreotide on the circulating levels of chromogranin-A, prostate-specific antigen, and insulin-like growth factor-1 in advanced prostate cancer patients

scientific article

Enzalutamide withdrawal syndrome: is there a rationale?

scientific article published on 01 March 2015

Feasibility of 21-day continuous infusion of epirubicin in hormone-refractory prostate cancer patients

scientific article

Independent prognostic role of circulating chromogranin A in prostate cancer patients with hormone-refractory disease.

scientific article published in March 2005

MDM2 gene amplification as selection tool for innovative targeted approaches in PD-L1 positive or negative muscle-invasive urothelial bladder carcinoma

scientific article published on 03 November 2020

Management of the side-effects of intravenous bisphosphonates: targeting the serum parathyroid hormone elevation

scientific article published on 25 August 2006

Oral estramustine plus oral etoposide in the treatment of hormone refractory prostate cancer patients: a phase II study with a 5-year follow-up

scientific article published in January 2005

Potential clinical value of circulating chromogranin A in patients with prostate carcinoma

scientific article

Predictive factors for skeletal complications in hormone-refractory prostate cancer patients with metastatic bone disease.

scientific article published on September 2005

Predictors of long-term response to abiraterone in patients with metastastic castration-resistant prostate cancer: a retrospective cohort study.

scientific article published on 19 May 2016

Prognostic factors in patients receiving third line targeted therapy for metastatic renal cell carcinoma.

scientific article published on 26 November 2014

Prognostic significance of disordered calcium metabolism in hormone-refractory prostate cancer patients with metastatic bone disease.

scientific article

Real-World Data on Cabozantinib in Previously Treated Patients with Metastatic Renal Cell Carcinoma: Focus on Sequences and Prognostic Factors

scientific article published on 30 December 2019

Relationship between neuroendocrine features and prognostic parameters in human prostate adenocarcinoma

scientific article published on 01 January 2001

Somatostatin receptors: from basic science to clinical approach. Unlabeled somatostatin analogues-1: Prostate cancer.

scientific article published on February 2004

Store-operated Ca2+ entry does not control proliferation in primary cultures of human metastatic renal cellular carcinoma.

scientific article

Sunitinib, pazopanib or sorafenib for the treatment of patients with late relapsing metastatic renal cell carcinoma

scientific article published on 18 July 2014

Targeting PI3K/Akt/mTOR Signaling in Cancer

scientific article published on 14 April 2014

Toward a genome-based treatment landscape for renal cell carcinoma

scientific article published on 02 August 2019

Paulina is supported by:

About Paulina

Help